Matthew B Maas1, Michael D Berman2, James C Guth3, Eric M Liotta2, Shyam Prabhakaran2, Andrew M Naidech2. 1. Department of Neurology, Northwestern University, Chicago, Illinois. Electronic address: mbmaas@northwestern.edu. 2. Department of Neurology, Northwestern University, Chicago, Illinois. 3. Department of Neurology, Loma Linda University, Loma Linda, California.
Abstract
BACKGROUND: We sought to determine whether a quantitative neurocheck biomarker could characterize the temporal pattern of early neurologic changes after intracerebral hemorrhage (ICH), and the impact of those changes on long-term functional outcomes. METHODS: We enrolled cases of spontaneous ICH in a prospective observational study. Patients underwent a baseline Glasgow Coma Scale (GCS) assessment, then hourly neurochecks using the GCS in a neuroscience intensive care unit. We identified a period of heightened neurologic instability by analyzing the average hourly rate of GCS change over 5 days from symptom onset. We used a multivariate regression model to test whether those early GCS score changes were independently associated with 3-month outcome measured by the modified Rankin Scale (mRS). RESULTS: We studied 13,025 hours of monitoring from 132 cases. The average rate of neurologic change declined from 1.0 GCS points per hour initially to a stable baseline of .1 GCS points per hour beyond 12 hours from symptom onset (P < .05 for intervals before 12 hours). Change in GCS score within the initial 12 hours was an independent predictor of mRS at 3 months (odds ratio, .81 [95% confidence interval, .66-.99], P = .043) after adjustment for age, hematoma volume, hematoma location, initial GCS, and intraventricular hemorrhage. CONCLUSIONS: Neurochecks are effective at detecting clinically important neurologic changes in the intensive care unit setting that are relevant to patients' long-term outcomes. The initial 12 hours is a period of frequent and prognostically important neurologic changes in patients with ICH.
BACKGROUND: We sought to determine whether a quantitative neurocheck biomarker could characterize the temporal pattern of early neurologic changes after intracerebral hemorrhage (ICH), and the impact of those changes on long-term functional outcomes. METHODS: We enrolled cases of spontaneous ICH in a prospective observational study. Patients underwent a baseline Glasgow Coma Scale (GCS) assessment, then hourly neurochecks using the GCS in a neuroscience intensive care unit. We identified a period of heightened neurologic instability by analyzing the average hourly rate of GCS change over 5 days from symptom onset. We used a multivariate regression model to test whether those early GCS score changes were independently associated with 3-month outcome measured by the modified Rankin Scale (mRS). RESULTS: We studied 13,025 hours of monitoring from 132 cases. The average rate of neurologic change declined from 1.0 GCS points per hour initially to a stable baseline of .1 GCS points per hour beyond 12 hours from symptom onset (P < .05 for intervals before 12 hours). Change in GCS score within the initial 12 hours was an independent predictor of mRS at 3 months (odds ratio, .81 [95% confidence interval, .66-.99], P = .043) after adjustment for age, hematoma volume, hematoma location, initial GCS, and intraventricular hemorrhage. CONCLUSIONS: Neurochecks are effective at detecting clinically important neurologic changes in the intensive care unit setting that are relevant to patients' long-term outcomes. The initial 12 hours is a period of frequent and prognostically important neurologic changes in patients with ICH.
Authors: J T Lindsay Wilson; Asha Hareendran; Marie Grant; Tracey Baird; Ursula G R Schulz; Keith W Muir; Ian Bone Journal: Stroke Date: 2002-09 Impact factor: 7.914
Authors: Craig S Anderson; Emma Heeley; Yining Huang; Jiguang Wang; Christian Stapf; Candice Delcourt; Richard Lindley; Thompson Robinson; Pablo Lavados; Bruce Neal; Jun Hata; Hisatomi Arima; Mark Parsons; Yuechun Li; Jinchao Wang; Stephane Heritier; Qiang Li; Mark Woodward; R John Simes; Stephen M Davis; John Chalmers Journal: N Engl J Med Date: 2013-05-29 Impact factor: 91.245
Authors: Matthew B Maas; Neil F Rosenberg; Adam R Kosteva; Rebecca M Bauer; James C Guth; Eric M Liotta; Shyam Prabhakaran; Andrew M Naidech Journal: Neurology Date: 2013-06-05 Impact factor: 9.910
Authors: Mitchell F Berman; Robert A Solomon; Stephan A Mayer; S Claiborne Johnston; Pixie P Yung Journal: Stroke Date: 2003-08-07 Impact factor: 7.914
Authors: Matthew B Maas; Brandon A Francis; Rajbeer S Sangha; Bryan D Lizza; Eric M Liotta; Andrew M Naidech Journal: Cerebrovasc Dis Date: 2017-01-04 Impact factor: 2.762
Authors: Katharine Colton; Christopher T Richards; Peter B Pruitt; Scott J Mendelson; Jane L Holl; Andrew M Naidech; Shyam Prabhakaran; Matthew B Maas Journal: J Stroke Cerebrovasc Dis Date: 2019-12-12 Impact factor: 2.136
Authors: Airton Leonardo de Oliveira Manoel; Alberto Goffi; Fernando Godinho Zampieri; David Turkel-Parrella; Abhijit Duggal; Thomas R Marotta; R Loch Macdonald; Simon Abrahamson Journal: Crit Care Date: 2016-09-18 Impact factor: 9.097
Authors: Matthew B Maas; Bryan D Lizza; Minjee Kim; Maged Gendy; Eric M Liotta; Kathryn J Reid; Phyllis C Zee; James W Griffith Journal: Neurocrit Care Date: 2020-10-22 Impact factor: 3.210
Authors: Jamie Nicole LaBuzetta; Brian R Hirshman; Atul Malhotra; Robert L Owens; Biren B Kamdar Journal: J Intensive Care Med Date: 2021-07-05 Impact factor: 2.889